Atypical adenomatous hyperplasia

Atypical adenomatous hyperplasia is a subtype of pneumocytic hyperplasia in the lung. It can be a precursor lesion of in situ adenocarcinoma of the lung (bronchioloalveolar carcinoma). In prostate tissue biopsy, it can be confused for adenocarcinoma of the prostate. The needle biopsy rate is less than 1%.

Pathology

Morphological differential diagnosis

Variants
  • multiple atypical adenomatous hyperplasia[2]
  • disseminated AAH[3]

Histopathological images
gollark: Rule 4, utter people.
gollark: Rule 4 you, utter dodecahedra.
gollark: I thought gnobody was no longer staff?
gollark: By rules something and something I am fully authorised to apply any punishment whatsoever which I am capable of against people who violate this.
gollark: Rule 4, bee entities.

See also

References
  1. Kobashi, Y; Sugiu, T; Mouri, K; Irei, T; Nakata, M; Oka, M (2008). "Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: Differentiation from multiple atypical adenomatous hyperplasia". Japanese Journal of Clinical Oncology. 38 (6): 451–4. doi:10.1093/jjco/hyn042. PMID 18535095.
  2. Kobashi, Y; Sugiu, T; Mouri, K; Irei, T; Nakata, M; Oka, M (2008). "Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis: Differentiation from multiple atypical adenomatous hyperplasia". Japanese Journal of Clinical Oncology. 38 (6): 451–4. doi:10.1093/jjco/hyn042. PMID 18535095.
  3. Pastorino, U; Calabrò, E; Tamborini, E; Marchianò, A; Orsenigo, M; Fabbri, A; Sozzi, G; Novello, S; De Marinis, F (2009). "Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib". Journal of Thoracic Oncology. 4 (2): 266–7. doi:10.1097/JTO.0b013e3181952930. PMID 19179908.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.